To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Nearly three decades since the remarkable cloning of Dolly the sheep, it has all gone quiet on the human cloning front.

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...